NCT00657371

Brief Summary

The purpose of this study is to demonstrate efficacy of the Avantis Third Eye Retroscope auxiliary imaging system. The primary objective of this study is to assess the degree to which incorporating the Third Eye Retroscope auxiliary imaging system in a screening colonoscopy setting results in the detection of additional polyps. Specifically, the primary goals are to estimate (1) the proportion of polyps detected under this protocol that would have been missed without the Third Eye Retroscope, and (2) the proportion of patients found under this protocol to have polyps who would have incorrectly been classified as polyp-free had the Third Eye Retroscope not been used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
288

participants targeted

Target at P50-P75 for not_applicable colorectal-cancer

Timeline
Completed

Started Mar 2008

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2008

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 8, 2008

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 14, 2008

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

December 9, 2013

Completed
Last Updated

December 9, 2013

Status Verified

October 1, 2013

Enrollment Period

2.2 years

First QC Date

April 8, 2008

Results QC Date

October 11, 2013

Last Update Submit

October 11, 2013

Conditions

Keywords

Colorectal CancerColonoscopyThird Eye RetroscopeThird Eye Retroscope Auxiliary Imaging SystemPolypectomy

Outcome Measures

Primary Outcomes (2)

  • Increase (Percent) of Polyps Detected That Would Have Been Missed Without the Third Eye Retroscope (TER)

    After cecal intubation, the disposable TER was inserted through the instrument channel of the colonoscope. During withdrawal, the forward and retrograde video images were observed simultaneously on a wide-screen monitor. A 2 year study period was used to collect colonoscopy exam results.

    Total 30 minutes procedure time with TER use.

  • Number Polyps Detected With the Standard Colonoscope and Third Eye Retroscope (TER)

    After cecal intubation, the disposable TER was inserted through the instrument channel of the colonoscope. During withdrawal, the forward and retrograde video images were observed simultaneously on a wide-screen monitor. A 2 year study period was used to collect colonoscopy exam results.

    Total 30 minutes procedure time with TER use.

Secondary Outcomes (1)

  • Number Participants With Polyps Who Would Have Incorrectly Been Classified as Polyp-free Had the Third Eye Retroscope Not Been Used.

    2 year study period to collect colonoscopy exam results

Study Arms (1)

Third Eye Retroscope

EXPERIMENTAL

Colonoscopy exam using the Third Eye Retroscope device

Device: Third Eye Retroscope Auxiliary Imaging System

Interventions

A thin, flexible probe that is inserted in a standard colonoscope in order to display very detailed images of the colon tissue.

Third Eye Retroscope

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient is undergoing colonoscopy for screening purposes or for surveillance in follow-up for previous polypectomy.
  • The patient is at satisfactory risk for abdominal surgery.
  • The patient must understand and provide written consent for the procedure.

You may not qualify if:

  • Patients who are \<50 years or \>80 years of age
  • Patients who are pregnant.
  • Patients with history of colonic resection.
  • Patients requiring ongoing anticoagulation therapy.
  • Patients with a history of severe cardiovascular, pulmonary, liver or renal disease.
  • Patients with hypersensitivity to opioid analgesics.
  • Patients with an active systemic infection.
  • Patients with suspected chronic stricture potentially precluding complete colonoscopy.
  • Patients with major psychiatric disease (dementia, schizophrenia or depression).
  • Patients with diverticulitis or toxic megacolon.
  • Patients with history of radiation therapy to abdomen or pelvis.
  • Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Mayo Clinic

Scottsdale, Arizona, 85259, United States

Location

El Camino Hospital

Mountain View, California, 94040, United States

Location

Camino Medical Group Surgi-Center

Sunnyvale, California, 94086, United States

Location

Indiana University Medical Center

Indianapolis, Indiana, 46202, United States

Location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Washington University

St Louis, Missouri, 63130, United States

Location

U.T.M.D. Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Publications (1)

  • Waye JD, Heigh RI, Fleischer DE, Leighton JA, Gurudu S, Aldrich LB, Li J, Ramrakhiani S, Edmundowicz SA, Early DS, Jonnalagadda S, Bresalier RS, Kessler WR, Rex DK. A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos). Gastrointest Endosc. 2010 Mar;71(3):551-6. doi: 10.1016/j.gie.2009.09.043. Epub 2009 Dec 16.

Related Links

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Results Point of Contact

Title
Robert S. Bresalier, MD / Professor
Organization
UT MD Anderson Cancer Center

Study Officials

  • Robert S. Bresalier, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2008

First Posted

April 14, 2008

Study Start

March 1, 2008

Primary Completion

May 1, 2010

Study Completion

May 1, 2010

Last Updated

December 9, 2013

Results First Posted

December 9, 2013

Record last verified: 2013-10

Locations